Medicare Spending Would Increase $2.0 to $5.1 Billion With Lecanemab
THURSDAY, May 18, 2023 (HealthDay News) — If eligible patients received lecanemab, Medicare would spend an extra $2.0 to $5.1 billion annually, according to a research letter published online May 11 in JAMA Internal Medicine to coincide with the annu…
Learn MoreColchicine Price Increase Tied to Poorer Gout Control Over a Decade
WEDNESDAY, May 17, 2023 (HealthDay News) — A sharp increase in colchicine prices in 2010 was associated with a sustained decrease in colchicine use and poorer disease control over a decade, according to a study published online May 8 in JAMA Internal…
Learn MoreA Swallowable Gastric Balloon Helps People Shed Pounds
WEDNESDAY, May 17, 2023 (HealthDay News) — Combining a swallowable gastric balloon with a weight loss drug may be a way to lose significant body weight, a new study suggests. In about eight months of combination treatment, participants lost an averag…
Learn MoreFDA Panel Recommends Approval of First Nasal Spray to Combat Severe Allergic Reactions
FRIDAY, May 12, 2023 (HealthDay News) — Outside advisers for the U.S. Food and Drug Administration voted Thursday to recommend approval of Neffy, the first epinephrine nasal spray for severe allergic reactions.Although most of the Pulmonary-Allergy D…
Learn MoreGet Relief With the Most Common Asthma Medications
FRIDAY, May 12, 2023 (HealthDay News) — Receiving a diagnosis of asthma may be frightening, but learning what the treatment options are can help alleviate the anxiety that comes with diagnosis. Depending on the severity, certain asthma medications ma…
Learn MoreGet Relief With the Most Common Asthma Medications
FRIDAY, May 12, 2023 (HealthDay News) — Receiving a diagnosis of asthma may be frightening, but learning what the treatment options are can help alleviate the anxiety that comes with diagnosis. Depending on the severity, certain asthma medications ma…
Learn MoreAddition of GLP1-RA Tied to Lower MACE, Heart Failure Risk in Those With Diabetes
FRIDAY, May 12, 2023 (HealthDay News) — For individuals with diabetes without preexisting cardiovascular disease, the addition of glucagon-like peptide 1 receptor agonists (GLP1-RA) is associated with a lower risk for major adverse cardiac events (MA…
Learn MoreFDA Approves First Drug Meant to Ease Alzheimer Disease-Linked Agitation
THURSDAY, May 11, 2023 (HealthDay News) — A medication to treat agitation in patients with Alzheimer disease now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval for Rexulti (brexpiprazole) oral tablets on Th…
Learn MoreThe Most Common Allergy Medicines
THURSDAY, May 11, 2023 (HealthDay News) — If you suffer from allergies, you know how bothersome and uncomfortable the sneezing and itchy eyes can be. These symptoms are more than irritating — they impact day-to-day activities like work, school, sport…
Learn MorePharmacologic Therapies Effective for Excessive Daytime Sleepiness
WEDNESDAY, May 10, 2023 (HealthDay News) — For patients with obstructive sleep apnea (OSA), solriamfetol, armodafinil-modafinil, and pitolisant reduce daytime sleepiness, with solriamfetol likely superior, according to a systematic review and meta-an…
Learn More